Expression patterns of fatty acid binding proteins in breast cancer cells

Journal of Experimental Therapeutics and Oncology

Volumn 5, Issue 2, 2005, Pages 133-143

  Hammamieh, Rasha ^a   Chakraborty, Nabarun ^a   Barmada, Mohsen ^a   Das, Rina ^a   Jett, Marti ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WRAIR   (United States)

Author keywords

Apoptosis; Breast cancer; Fatty acid binding proteins; L FABP; MCF 7; Microarray

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; FATTY ACID BINDING PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION;

EID: 28444439843     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bass, N. M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function, Int Rev Cytol, 111: 143-184. 1988.
2. Garlid, K. D., Jaburek, M., and Jezek, P. The mechanism of proton transport mediated by mitochondrial uncoupling proteins. FEES Lett, 438: 10-14. 1998.
3. Huynh, H. T., Larsson, C., Narod, S. and Pollak, M. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res, 55: 2225-2231. 1995.
4. Chen, S. H., Van Tuinen, P., Ledbetter, D. H., Smith, L. C., and Chan, L., Human liver fatty acid binding protein gene is located on chromosome 2. Somat Cell Mol Genet, 12: 303-306. 1986.
5. Das, R., Hammamieh, R., Neill, R., Melhem, M. and Jett, M. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res, 7: 1706-1715. 2001.
6. De Santis, M. L., Hammamieh, R., Das, R. and Jett, M. Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells. J Exp Ther Oncol, 4: 91-100. 2004.
7. Hammamieh, R., Chakraborty, N., Das, R. and Jett, M. Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro. J Exp Ther Oncol, 4: 195-202. 2004.
8. Meunier-Durmort, C., Poirier, H., Niot, I., Forest, C. and Besnard, P. Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J, 319 (Pt 2): 483-487. 1996.
9. Suzuki, T., Watanabe, K. and Ono, T. Immunohistochemical demonstration of liver fatty acid-binding protein in human hepatocellular malignancies. J Pathol, 161: 79-83. 1990.
10. Rajaraman, G. and Burczynski, F. J. Effect of dexamethasone, 2-bromopalmitate and clofibrate on L-FABP mediated hepatoma proliferation. J Pharm Pharmacol, 56: 1155-1161. 2004.
11. Hashimoto, T., Kusakabe, T., Watanabe, K., Sugino, T., Fukuda, T, Nashimoto, A., Honma, K., Sato, Y., Kimura, H., Fujii, H. and Suzuki, T. Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma. Pathobiology, 71: 115-122. 2004.
12. Basolo, F., Calvo, S., Fiore, L., Conaldi, P. G., Falcone, V. and Toniolo, A. Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene. Cancer Res, 53: 2957-2960. 1993.
13. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K. and Taniguchi, T. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature, 424: 516-523. 2003.
14. Kamali-Sarvestani, E., Gharesi-Fard, B., Sarvari, J. and Talei, A. A. Association of TNF-α and TNF-β Gene Polymorphism with Steroid Receptor Expression in Breast Cancer Patients. Pathol Oncol Res, 11: 99-102. 2005.
15. Xu, Q. and Reed, J. C. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell, 1: 337-346.1998.
16. Schule, J. M., Bergkvist, L., Hakansson, L., Gustafsson, B. and Hakansson, A. CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression. J Transl Med, 2: 45. 2004.
17. Miyoshi, J, and Takai, Y. Dual role of DENN/MADD (Rab3GEP) in neurotransmission and neuroprotection. Trends Mol Med, 10: 476-480. 2004.
18. Lahiri, M. and Martin, J. H. Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line. Oncol Rep, 12: 1007-1011. 2004.
19. Loibl, S., Strank, C., von Minckwitz, G., Sinn, H. P., Buck, A., Solbach, C., Strebhardt, K. and Kaufmann, M. Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer. Breast, 14: 230-235. 2005.
20. Zhou, Y., Bian, X., Le, Y, Gong, W., Hu, J., Zhang, X., Wang, L., Iribarren, P., Salcedo, R., Howard, O. M., Farrar, W. and Wang, J. M. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst, 97: 823-835. 2005.
21. Lin, S. Y. and Elledge, S. J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell, 113: 881-889. 2003.
22. Shay, J. W., Zou, Y, Hiyama, E. and Wright, W. E. Telomerase and cancer. Hum Mol Genet, 10: 677-685. 2001.
23. Rossi, M., Abbondanza, C., D'Arcangelo, A., Gazzerro, P., Medici, N., Moncharmont, B. and Puca, G. A. The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. Cancer Lett, 215: 229-237. 2004.
24. Wolffe, A. P. Histone deacetylase: a regulator of transcription. Science, 272: 371-372. 1996.
25. Hanks, S. K., Armour, R., Baldwin, J. H., Maldonado, F., Spiess, J. and Holley, R. W. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA, 85: 79-82. 1988.
26. Camirand, A., Zakikhani, M., Young, F. and Pollak, M. Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells. Breast Cancer Res, 7: R570-579. 200 5 .
27. Burger, A. M., Leyland-Jones, B., Banerjee, K., Spyropoulos, D. D. and Seth, A. K. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer, 2005.
28. Nicholson, R. I., Hutcheson, I. R., Britton, D., Knowlden, J. M., Jones, H. E., Harper, M. E., Hiscox, S. E., Barrow, D. and Gee, J. M. Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. J Steroid Biochem Mol Biol, 93: 257-262. 2005.
29. Lichtner, R. B. Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies. Biomed Pharmacother, 57: 447-451. 2003.
30. Wittenmayer, N., Jandrig, B., Rothkegel, M., Schluter, K., Arnold, W., Haensch, W., Scherneck, S. and Jockusch, B. M. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell, 15: 1600-1608. 2004.
31. Babic, A. M., Kireeva, M. L., Kolesnikova, T. V. and Lau, L. F. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA, 95: 6355-6360. 1998.
32. Clezardin, P., Bruno-Bossio, G., Fontana, A., Serre, C. M., Magnetto, S. and Frappart, L. [Thrombospondins, tumor angiogenesis and breast cancer]. Pathol Biol (Paris), 47: 368-374. 1999.
33. Volpert, O. V., Zaichuk, T., Zhou, W., Reiher, F., Ferguson, T. A., Stuart, P. M., Amin, M. and Bouck, N. P. Inducerstimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med, 8: 349-357. 2002.